Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bizzini

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunityO Picard, A Achour, J Bernard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparationsC Carelli, A Halbreich, J Bernard, et al.
Journal of Human Virology|July 5, 2001
Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cellsR D'Anna, H Le Buanec, B Bizzini, et al.
Computer Applications in the Biosciences : CABIOS|April 1, 1994
Automat: a novel software system for the systematic search for protein (or DNA) similarities with a notable application to autoimmune diseases and AIDSH Cantalloube, C Nahum, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 2, 2001
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routesH Le Buanec, C Vetu, A Lachgar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activationV Chams, D Biou, Y Y Cho, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodiesA Lachgar, J Bernard, B Bizzini, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Anti-alpha interferon immunization: safety and immunogenicity in asymptomatic HIV positive patients at high risk of disease progressionA Gringeri, E Santagostino, P M Mannucci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Biological effect of active anti-IFN alpha immunization in HIV-infected patientsL S Fall, J P M'Bika, H Le Coq, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategyD Zagury, J Bernard, A Halbreich, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunityO Picard, A Achour, J Bernard, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1992
Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparationsC Carelli, A Halbreich, J Bernard, et al.
Journal of Human Virology|July 5, 2001
Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cellsR D'Anna, H Le Buanec, B Bizzini, et al.
Computer Applications in the Biosciences : CABIOS|April 1, 1994
Automat: a novel software system for the systematic search for protein (or DNA) similarities with a notable application to autoimmune diseases and AIDSH Cantalloube, C Nahum, A Achour, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 2, 2001
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routesH Le Buanec, C Vetu, A Lachgar, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1994
Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activationV Chams, D Biou, Y Y Cho, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1996
Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodiesA Lachgar, J Bernard, B Bizzini, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
Anti-alpha interferon immunization: safety and immunogenicity in asymptomatic HIV positive patients at high risk of disease progressionA Gringeri, E Santagostino, P M Mannucci, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1995
Biological effect of active anti-IFN alpha immunization in HIV-infected patientsL S Fall, J P M'Bika, H Le Coq, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategyD Zagury, J Bernard, A Halbreich, et al.
Pageof 16